Soshi Nagaoka
About
In The Last Decade
Soshi Nagaoka
9 papers receiving 568 citations
Hit Papers
Peers
Comparison fields: 5 of 36
- Surgery 528
- Pulmonary and Respiratory Medicine 346
- Oncology 337
- Pathology and Forensic Medicine 87
- Molecular Biology 45
Countries citing papers authored by Soshi Nagaoka
This map shows the geographic impact of Soshi Nagaoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soshi Nagaoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soshi Nagaoka more than expected).
Fields of papers citing papers by Soshi Nagaoka
This network shows the impact of papers produced by Soshi Nagaoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soshi Nagaoka. The network helps show where Soshi Nagaoka may publish in the future.
Co-authorship network of co-authors of Soshi Nagaoka
This figure shows the co-authorship network connecting the top 25 collaborators of Soshi Nagaoka. A scholar is included among the top collaborators of Soshi Nagaoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soshi Nagaoka. Soshi Nagaoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 8 | |
| 7 | [Incidence of Proteinuria among Japanese Colorectal Cancer Patients after Receiving Ramucirumab-Cohort Study Using Claim Database]. | 0 |
| 8 | 2 | |
| 9 | 12 | |
| 10 | 1 | |
| 11 | Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan breakdown → | 541 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.